CCG-1423(CCG1423) RhoA通路抑制剂|CAS 285986-88-1（53515ES）

CCG-1423 (CCG1423)是RhoA转录信号抑制剂，选择性抑制SRF介导的被Rho信号通路激活的转录，具有抗癌活性。CG-1423选择性地抑制Rho过表达细胞系中的DNA合成、增殖和侵袭。

参考文献

.Evelyn CR, et al. CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling. Mol Cancer Ther. 2007 Aug;6(8):2249-60.

2.Chong NW, et al. STARS is essential to maintain cardiac development and function in vivo via a SRF pathway. PLoS One. 2012;7(7):e40966.

3.Johnson LA, et al. Novel Rho/MRTF/SRF inhibitors block matrix-stiffness and TGF-β-induced fibrogenesis in human colonic myofibroblasts. Inflamm Bowel Dis. 2014 Jan;20(1):154-65.

冰袋运输。粉末直接保存于-20℃，有效期3年。建议分装后-20℃干燥保存，避免反复冻融。